• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Robert Langreth

Stay informed with Robert Langreth’s coverage and analysis.

J&J says COVID booster dose provides 100% protection against severe disease
Health
J&J says COVID booster dose provides 100% protection against severe disease
By Robert Langreth and BloombergSeptember 21, 2021
Pfizer headquarters
Health
FDA panel recommends COVID-19 boosters only for those 65 and older or at high risk
By Robert Langreth, Fiona Rutherford and BloombergSeptember 17, 2021
Moderna files for FDA authorization for a third-dose COVID booster shot
Health
Moderna files for FDA authorization for a third-dose COVID booster shot
By Robert Langreth and BloombergSeptember 2, 2021
Pfizer submits early data on the effects of third booster dose to FDA
Health
Pfizer submits early data on the effects of third booster dose to FDA
By Riley Griffin, Robert Langreth and BloombergAugust 16, 2021
FDA to green-light a third COVID shot for those with compromised immune system
Health
FDA to green-light a third COVID shot for those with compromised immune system
By Robert Langreth, Josh Wingrove and BloombergAugust 12, 2021
Moderna plans to build a vaccine factory in Canada that produces COVID shots
Health
Moderna plans to build a vaccine factory in Canada that produces COVID shots
By Robert Langreth and BloombergAugust 10, 2021
Eli Lilly’s shares rises to highest since June as Alzheimer’s treatment nears final-stage trial
Finance
Eli Lilly’s shares rises to highest since June as Alzheimer’s treatment nears final-stage trial
By Robert Langreth and BloombergAugust 3, 2021
How COVID-19 came raging back in 2021
Health
How COVID-19 came raging back in 2021
By James Paton, Robert Langreth and BloombergJuly 27, 2021
Pfizer vaccine
Health
Pfizer will seek FDA approval of a COVID vaccine booster shot in August
By Robert Langreth and BloombergJuly 8, 2021
Early coronavirus samples were removed from a U.S. database at the request of Chinese researchers
Health
Early coronavirus samples were removed from a U.S. database at the request of Chinese researchers
By Rachel Chang, Robert Langreth and BloombergJune 24, 2021
Moderna COVID vaccine up to 100% effective in teens
Health
Moderna COVID vaccine up to 100% effective in teens
By Robert Langreth and BloombergMay 25, 2021
Novavax shares soar after strong trial results for COVID-19 vaccine
Health
Novavax shares soar after strong trial results for COVID-19 vaccine
By Bloomberg and Robert LangrethJanuary 29, 2021
Moderna raises 2021 vaccine output outlook to at least 600 million doses
Health
Moderna raises 2021 vaccine output outlook to at least 600 million doses
By Robert Langreth and BloombergJanuary 4, 2021
Moderna vaccine cleared in U.S., boosting immunization effort
Health
Moderna vaccine cleared in U.S., boosting immunization effort
By Anna Edney, Robert Langreth and BloombergDecember 18, 2020
Moderna to request clearance for COVID-19 vaccine in U.S. and EU
Health
Moderna to request clearance for COVID-19 vaccine in U.S. and EU
By Bloomberg and Robert LangrethNovember 30, 2020
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeJune 27, 2026
Success
Elon Musk on MacKenzie Scott giving away $26 billion of her fortune: 'Sadly,' it makes the world a worse placeplaceholder alt text
By Sydney LakeJune 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.